Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epi-drugs as triple-negative breast cancer treatment
Mouhamed Idrissou, Anna Sánchez, Frédérique Penault‐Llorca, et al.
Epigenomics (2020) Vol. 12, Iss. 8, pp. 725-742
Closed Access | Times Cited: 17

Showing 17 citing articles:

New Perspectives for Resistance to PARP Inhibitors in Triple-Negative Breast Cancer
Ye Han, Xiaopeng Yu, Shuqiang Li, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 56
Epigenetic Therapies in Triple-Negative Breast Cancer: Concepts, Visions, and Challenges
Ulrich Lehmann
Cancers (2024) Vol. 16, Iss. 12, pp. 2164-2164
Open Access | Times Cited: 6
Role of histone demethylases and histone methyltransferases in triple-negative breast cancer: Epigenetic mnemonics
Janice Jacson Mandumpala, Stephin Baby, Antriya Annie Tom, et al.
Life Sciences (2022) Vol. 292, pp. 120321-120321
Closed Access | Times Cited: 21
Combating breast cancer progression through combination therapy with hypomethylating agent and glucocorticoid
Yu-Hsin Chu, Yi-Chen Huang, Pei-Yun Chiu, et al.
iScience (2023) Vol. 26, Iss. 5, pp. 106597-106597
Open Access | Times Cited: 5
Discovery of Antiproliferative Activity of Novel Bisurea Derivatives Induces Apoptosis in MDA-MB-231 Breast Cancer Cells
Nagalakshmamma Vadabingi, ME Rani
Journal of Advanced Scientific Research (2024) Vol. 15, Iss. 05, pp. 7-11
Open Access | Times Cited: 1
Antagonistic Pharmacological Interaction between Sirtuin Inhibitor Cambinol and Paclitaxel in Triple-Negative Breast Cancer Cell Lines: An Isobolographic Analysis
Anna Wawruszak, Jarogniew J. Łuszczki, Estera Okoń, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6458-6458
Open Access | Times Cited: 7
An Overview Regarding Pharmacogenomics and Biomarkers Discovery: Focus on Breast Cancer
Thalita Basso Scandolara, Bruno Ricardo Barreto Pires, Beatriz Geovana Leite Vacario, et al.
Current Topics in Medicinal Chemistry (2022) Vol. 22, Iss. 20, pp. 1654-1673
Closed Access | Times Cited: 5
Epigenetic Reprogramming and Landscape of Transcriptomic Interactions: Impending Therapeutic Interference of Triple-Negative Breast Cancer in Molecular Medicine
Suman Kumar Ray, Sukhes Mukherjee
Current Molecular Medicine (2021) Vol. 22, Iss. 10, pp. 835-850
Closed Access | Times Cited: 6
Epigenetic Targeting of Cancer
Jacob Cawley
CABI eBooks (2023), pp. 181-198
Closed Access | Times Cited: 2
Interobserver Variability in Cervical Smears from Patients with a History of Abnormal Cytology: Comparison of Conventional Pap Smears and Liquid-Based Cytology
İlknur Türkmen, Nuray Başsüllü, Banu Bingöl, et al.
Erciyes Medical Journal (2013) Vol. 35, Iss. 1, pp. 13-17
Open Access | Times Cited: 2
Epigenetic memory in breast cancer: electrochemical biosensor-based tracing of histone H3 acetylation inheritance
Mahya Ahmadpour Youshanlui, Milad Shirvaliloo
Epigenomics (2023) Vol. 15, Iss. 3, pp. 111-114
Closed Access | Times Cited: 1
Histone Modifying Potential of Dietary Phytochemicals: Implications in Treating Breast Cancer
Aishwarya Laxmi, Sourbh Suren Garg, Arnika Singh, et al.
Current Pharmacology Reports (2023) Vol. 9, Iss. 6, pp. 489-510
Closed Access | Times Cited: 1
Current Advances in Breast Cancer: Implications for Developing New Treatment Strategies Through Epi-Drugs on the Road to Modifying the Epigenome
Sercan Kenanoğlu
Journal of Clinical Practice and Research (2023), pp. 427-434
Open Access
Triagem de epi-drogas para a aplicação como terapia combinada na eliminação de células-tronco tumorais e reversão da quimiorresistência em câncer de cabeça e pescoço
Ana Patricia Espaladori Eskenazi
(2023)
Open Access
In Silico and Experimental Outcomes of the Expression of miR508-5p and miR-635 in Tumor Tissues of Patients with Breast Cancer

Iranian Red Crescent Medical Journal (2023)
Open Access
Test
Neelam Injeti
Future Journal of Pharmaceuticals and Health Sciences (2022) Vol. 2, Iss. 2, pp. 127-131
Open Access
In Silico and Experimental Outcomes of the Expression of miR508-5p and miR-635 in Tumor Compared with Non-Tumor Adjacent Tissues of Patients with Breast Cancer
Fatemeh Zeinali Sehrig, Mohammad Zaefizadeh, Changiz Ahmadizadeh, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top